CpG-ODN prevent pulmonary fibrosis by regulating the expression of Th1/Th2 cytokines
Creators
- 1. Department of radiotherapy, Lanzhou General Hospital of PLA, Lanzhou (China)
- 2. Faculty of Naval Medicine, The Second Military Medical University, Shanghai (China)
Description
To investigate the mechanism of CpG-ODN in the prevention of radiation pulmonary fibrosis by focusing on the regulation of balance between Th1/Th2 cytokines. The entire thorax of female C57BL/6 mice was exposed to a single radiation at a dose of 15 Gy. The Th1/Th2-related cytokines and profibrogenic cytokines were detected by enzyme linked immunosorbent assay for 20 weeks after radiation. Alveolar macrophages, pulmonary fibrosis, and phosphorylated Mitogen-activated protein kinase (MAPK) family proteins were detected by immunohistochemistry. The results suggested that CpG-ODN promoted Th1-related cytokine secretion and inhibited Th2-related cytokine secretion, leading to a predominantly Th1 immune response, reduced alveolar macrophage accumulation, and profibrogenic cytokine (TGF-β1 and IGF-1) expression, which may be involved in the inhibition of phosphorylation of MAPK family proteins. This indicates that CpG-ODN prevents pulmonary fibrosis by regulating the imbalance between Th1/Th2 after irradiation. (authors)
Additional details
Identifiers
Publishing Information
- Journal Title
- Journal of Radiation Research and Radiation Processing
- Journal Volume
- 37
- Journal Issue
- 1
- Journal Page Range
- [9 p.]
- ISSN
- 1000-3436
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 54049788
- Subject category
- S61: RADIATION PROTECTION AND DOSIMETRY; S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- CHEST; FEMALES; FIBROSIS; IRRADIATION; LYMPHOKINES; MACROPHAGES; MICE; PHOSPHORYLATION; PHOSPHOTRANSFERASES; RADIATION DOSES; RADIOPROTECTIVE SUBSTANCES
- Descriptors DEC
- ANIMAL CELLS; ANIMALS; BODY; CHEMICAL REACTIONS; CONNECTIVE TISSUE CELLS; DOSES; DRUGS; ENZYMES; GROWTH FACTORS; MAMMALS; MITOGENS; ORGANIC COMPOUNDS; PATHOLOGICAL CHANGES; PHAGOCYTES; PHOSPHORUS-GROUP TRANSFERASES; PROTEINS; RESPONSE MODIFYING FACTORS; RODENTS; SOMATIC CELLS; TRANSFERASES; VERTEBRATES
Optional Information
- Notes
- 7 figs., 1 tab., 19 refs.; http://dx.doi.org/10.11889/j.1000-3436.2019.rrj.37.010302